PYRROLOPYRAZINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS
申请人:Hadida Ruah Sara Sabina
公开号:US20120196869A1
公开(公告)日:2012-08-02
The invention relates to pyrrolopyrazine-spirocyclic piperidine amide compounds useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
CHROMAN-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS
申请人:HADIDA-RUAH Sara Sabina
公开号:US20120245136A1
公开(公告)日:2012-09-27
The invention relates to chroman spirocyclic piperidine amide derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
MORPHOLINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS
申请人:Hadida-Ruah Sara Sabina
公开号:US20120264749A1
公开(公告)日:2012-10-18
The invention relates to morpholine spirocyclic piperidine amide compounds useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
Pyran-Spirocyclic Piperidine Amides as Modulators of Ion Channels
申请人:Vertexs Pharmaceuticals Incorporated
公开号:US20150005304A1
公开(公告)日:2015-01-01
The invention relates to pyran spirocyclic piperidine amide compounds useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
Pyrrolopyrazine-Spirocyclic piperidine amides as modulators of ion channels
申请人:Vertex Pharmaceuticals Incorporated
公开号:US20150174127A1
公开(公告)日:2015-06-25
The invention relates to pyrrolopyrazine-spirocyclic piperidine amide compounds useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.